Latest filing published 19 Mar 2021 for Neos Therapeutics, Inc..
No signal scores available.
All filings by Linda M. Szyper on record concern Neos Therapeutics, Inc. Over a trading history stretching from 10 June 2020 to 19 March 2021, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 19 March 2021, the filings show a transaction in Neos Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations